As of January 24, 2025, SurModics (SRDX) has a market cap of $0.53 billion USD. According to our data, SurModics is ranked No.6044 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 24, 2025 | $0.53 B |
-6.34%
|
Dec 31, 2024 | $0.57 B |
8.94%
|
Dec 29, 2023 | $0.52 B |
6.54%
|
Dec 30, 2022 | $0.49 B |
-29.14%
|
Dec 31, 2021 | $0.69 B |
10.64%
|
Dec 31, 2020 | $0.62 B |
5.04%
|
Dec 31, 2019 | $0.59 B |
-12.34%
|
Dec 31, 2018 | $0.68 B |
68.79%
|
Dec 29, 2017 | $0.40 B |
10.24%
|
Dec 30, 2016 | $0.36 B |
25.31%
|
Dec 31, 2015 | $0.29 B |
-8.28%
|
Dec 31, 2014 | $0.32 B |
-9.39%
|
Dec 31, 2013 | $0.35 B |
9.08%
|
Dec 31, 2012 | $0.32 B |
52.52%
|
Dec 30, 2011 | $0.21 B |
23.50%
|
Dec 31, 2010 | $0.17 B |
-47.62%
|
Dec 31, 2009 | $0.32 B |
-10.33%
|
Dec 31, 2008 | $0.36 B |
-53.44%
|
Dec 31, 2007 | $0.78 B |
74.39%
|
Dec 29, 2006 | $0.44 B |
-15.87%
|
Dec 30, 2005 | $0.53 B |
13.78%
|
Dec 31, 2004 | $0.46 B |
36.94%
|
Dec 31, 2003 | $0.34 B |
-17.22%
|
Dec 31, 2002 | $0.41 B |
-21.34%
|
Dec 31, 2001 | $0.52 B |
-0.96%
|
Dec 29, 2000 | $0.53 B |
145.42%
|
Dec 31, 1999 | $0.21 B |
93.55%
|
Dec 31, 1998 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Abbott Laboratories
ABT
|
$213.72 B |
0.003 M
|
USA
|
Medtronic
MDT
|
$114.44 B |
-0.000 M
|
Ireland
|
Boston Scientific
BSX
|
$149.80 B |
-0.007 M
|
USA
|
Becton Dickinson
BDX
|
$69.74 B |
0.002 M
|
USA
|
Edwards Lifesciences
EW
|
$40.65 B |
-0.001 M
|
USA
|
Stryker Corporation
SYK
|
$150.01 B |
0.000 M
|
USA
|
Zimmer Biomet
ZBH
|
$22.10 B |
0.001 M
|
USA
|
Smith & Nephew
SNN
|
$11.00 B |
0.000 M
|
UK
|
Baxter
BAX
|
$16.25 B |
-0.000 M
|
USA
|
Integra LifeSciences
IART
|
$1.92 B |
-0.000 M
|
USA
|
Teleflex
TFX
|
$8.40 B |
0.000 M
|
USA
|
Globus Medical
GMED
|
$12.71 B |
2.093 B
|
USA
|
Penumbra
PEN
|
$10.59 B |
0.000 M
|
USA
|
Market Cap | = | SRDX Stock Price | * | SRDX Shares Outstanding |
= | $37.09 | * | 14.29 M | |
= | $0.53 B |